ÂÜÀòÂÒÂ×

Prof Alistair Strachan received his PhD in Biochemistry from the University of Strathclyde, Glasgow and his MBA from the University of Stellenbosch Graduate School Of Business, Cape Town. He has nearly 20 years’ experience in corporate pharma, spanning the generic and research-based industries, in South Africa, the US and the UK having held senior executive positions at the South African Druggists Group (COO of US subsidiary Capricorn Pharma Inc.), GlaxoSmithKline (Head of Operations Neurology & GI Centre of Excellence for Drug Discovery), Wyeth (Head of Operations for the US-based global Discovery organisation & VP and Head of Licensing and Business Development EMEA region) and Pfizer. Most recently, Alistair has been Head of Operations Global Biotherapeutics Technologies, Pfizer and site head of their Aberdeen, UK R&D operation. In addition, Alistair has served on the Country Coordinating Council of the Pfizer UK Board and on the Life Sciences Industry Advisory Board of the Scottish Government. In July 2012 he was made an Honorary Professor by the University of Aberdeen.